Non-State Actors and Public Health Emergencies
What are the specific legal and ethical implications of involving private actors in health care vis-à-vis public health emergencies?

What are the specific legal and ethical implications of involving private actors in health care vis-à-vis public health emergencies?
Infodemic management must be an integral part of public health emergency prevention, preparedness, response, and recovery.
Health emergencies happen: rights protections, solidarity should be central to response.
In this symposium, experts around the world reflect on the recently issued Principles and Guidelines on Human Rights and Public Health Emergencies.
What can the New York City Marathon teach those hoping to increase global vaccine equity? Quite a lot, it turns out.
Amid ongoing patent disputes over the mRNA platform, a significant scientific question remains unanswered: whether mRNA itself even is patent eligible.
Recent articles emphasize the need to reform intellectual property protections for government-funded inventions of public health significance.
Mapping the growth of U.S. innovation in the life sciences and computing fields from 1976-2021 through publicly available patent data.
If pharma giants truly are committed to addressing vaccine inequity, just building manufacturing capacity in Africa might not be enough.
An explanation of the key patents at stake in the intellectual property dispute between Moderna and Pfizer/BioNTech over COVID-19 vaccines.